These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23289593)

  • 21. Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment.
    Li C; Zheng X; Hu M; Jia M; Jin R; Nie Y
    Expert Opin Drug Deliv; 2022 Aug; 19(8):883-898. PubMed ID: 35760767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved in vitro models for preclinical drug and formulation screening focusing on 2D and 3D skin and cornea constructs.
    Beißner N; Bolea Albero A; Füller J; Kellner T; Lauterboeck L; Liang J; Böl M; Glasmacher B; Müller-Goymann CC; Reichl S
    Eur J Pharm Biopharm; 2018 May; 126():57-66. PubMed ID: 29191717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.
    Ma X; Qu X; Zhu W; Li YS; Yuan S; Zhang H; Liu J; Wang P; Lai CS; Zanella F; Feng GS; Sheikh F; Chien S; Chen S
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2206-11. PubMed ID: 26858399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Life in 3D is never flat: 3D models to optimise drug delivery.
    Fitzgerald KA; Malhotra M; Curtin CM; O' Brien FJ; O' Driscoll CM
    J Control Release; 2015 Oct; 215():39-54. PubMed ID: 26220617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteins: emerging carrier for delivery of cancer therapeutics.
    Yewale C; Baradia D; Vhora I; Misra A
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1429-48. PubMed ID: 23789923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a tissue-engineered colon cancer model for comparative analysis of cancer cell lines.
    Hassani I; Anbiah B; Moore AL; Abraham PT; Odeniyi IA; Habbit NL; Greene MW; Lipke EA
    J Biomed Mater Res A; 2024 Feb; 112(2):231-249. PubMed ID: 37927200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering a functional three-dimensional human cardiac tissue model for drug toxicity screening.
    Lu HF; Leong MF; Lim TC; Chua YP; Lim JK; Du C; Wan ACA
    Biofabrication; 2017 May; 9(2):025011. PubMed ID: 28393762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioengineered tumors.
    Villasante A; Vunjak-Novakovic G
    Bioengineered; 2015; 6(2):73-6. PubMed ID: 25616977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics.
    Hammel JH; Zatorski JM; Cook SR; Pompano RR; Munson JM
    Adv Drug Deliv Rev; 2022 Mar; 182():114111. PubMed ID: 35031388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.
    Smith AST; Davis J; Lee G; Mack DL; Kim DH
    Drug Discov Today; 2016 Sep; 21(9):1387-1398. PubMed ID: 27109386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies.
    Porter JR; Ruckh TT; Popat KC
    Biotechnol Prog; 2009; 25(6):1539-60. PubMed ID: 19824042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering.
    Mouriño V; Cattalini JP; Roether JA; Dubey P; Roy I; Boccaccini AR
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1353-65. PubMed ID: 23777443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models.
    Carvalho MR; Lima D; Reis RL; Oliveira JM; Correlo VM
    Stem Cell Rev Rep; 2017 Jun; 13(3):347-363. PubMed ID: 28233276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal Scaffold.
    Nietzer S; Baur F; Sieber S; Hansmann J; Schwarz T; Stoffer C; Häfner H; Gasser M; Waaga-Gasser AM; Walles H; Dandekar G
    Tissue Eng Part C Methods; 2016 Jul; 22(7):621-35. PubMed ID: 27137941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery.
    Ringuette Goulet C; Bernard G; Chabaud S; Couture A; Langlois A; Neveu B; Pouliot F; Bolduc S
    Biomaterials; 2017 Nov; 145():233-241. PubMed ID: 28888113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioengineered 3D Models to Recapitulate Tissue Fibrosis.
    Sacchi M; Bansal R; Rouwkema J
    Trends Biotechnol; 2020 Jun; 38(6):623-636. PubMed ID: 31952833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mimetic Hierarchical Approaches for Osteochondral Tissue Engineering.
    Gadjanski I
    Adv Exp Med Biol; 2018; 1058():143-170. PubMed ID: 29691821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers.
    Sadhukha T; O'Brien TD; Prabha S
    J Control Release; 2014 Dec; 196():243-51. PubMed ID: 25456830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-engineered oral mucosa.
    Moharamzadeh K; Colley H; Murdoch C; Hearnden V; Chai WL; Brook IM; Thornhill MH; Macneil S
    J Dent Res; 2012 Jul; 91(7):642-50. PubMed ID: 22266525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.